Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript November 7, 2024
Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.7, expectations were $0.06.
Operator: Greetings and welcome to Rigel Pharmaceutical’s Financial Conference Call for the Third Quarter 2024. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is...
